Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.
2.

Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread.

CichoĊ„ T, Jamrozy L, Glogowska J, Missol-Kolka E, Szala S.

Cancer Gene Ther. 2002 Sep;9(9):771-7.

3.

Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.

Ding I, Sun JZ, Fenton B, Liu WM, Kimsely P, Okunieff P, Min W.

Cancer Res. 2001 Jan 15;61(2):526-31.

4.

Endostatin expression by MDA-MB-435 breast cancer cells effectively inhibits tumor growth.

Liby K, Neltner B, Mohamet L, Burd C, Ben-Jonathan N.

Cancer Biol Ther. 2003 Jan-Feb;2(1):48-52.

PMID:
12673115
5.

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.

Chen CT, Lin J, Li Q, Phipps SS, Jakubczak JL, Stewart DA, Skripchenko Y, Forry-Schaudies S, Wood J, Schnell C, Hallenbeck PL.

Hum Gene Ther. 2000 Sep 20;11(14):1983-96.

PMID:
11020798
6.

Mouse endostatin inhibits the formation of lung and liver metastases.

Yoon SS, Eto H, Lin CM, Nakamura H, Pawlik TM, Song SU, Tanabe KK.

Cancer Res. 1999 Dec 15;59(24):6251-6.

7.

Antiangiogenic activity of endostatin inhibits C6 glioma growth.

Peroulis I, Jonas N, Saleh M.

Int J Cancer. 2002 Feb 20;97(6):839-45.

8.

Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.

Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP.

Cancer Res. 1999 Jan 1;59(1):189-97.

9.

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.

Mori K, Ando A, Gehlbach P, Nesbitt D, Takahashi K, Goldsteen D, Penn M, Chen CT, Mori K, Melia M, Phipps S, Moffat D, Brazzell K, Liau G, Dixon KH, Campochiaro PA.

Am J Pathol. 2001 Jul;159(1):313-20.

10.

Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells.

Pawliuk R, Bachelot T, Zurkiya O, Eriksson A, Cao Y, Leboulch P.

Mol Ther. 2002 Apr;5(4):345-51.

11.

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.

Jin X, Bookstein R, Wills K, Avanzini J, Tsai V, LaFace D, Terracina G, Shi B, Nielsen LL.

Cancer Gene Ther. 2001 Dec;8(12):982-9.

12.
13.
14.

Inhibition of tumor growth in mice by endostatin derived from abdominal transplanted encapsulated cells.

Teng H, Zhang Y, Wang W, Ma X, Fei J.

Acta Biochim Biophys Sin (Shanghai). 2007 Apr;39(4):278-84.

15.

Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.

Li M, Ye C, Feng C, Riedel F, Liu X, Zeng Q, Grandis JR.

Clin Cancer Res. 2002 Nov;8(11):3570-8.

16.

Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice.

Chen QR, Kumar D, Stass SA, Mixson AJ.

Cancer Res. 1999 Jul 15;59(14):3308-12.

17.

Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells.

Weiss JM, Shivakumar R, Feller S, Li LH, Hanson A, Fogler WE, Fratantoni JC, Liu LN.

Cancer Gene Ther. 2004 May;11(5):346-53.

PMID:
15031722
19.

Anti-tumor effect of human endostatin mediated by retroviral gene transfer in nude mice.

Wang X, Liu F, Li X, Li J, Xu G.

Chin Med J (Engl). 2002 Nov;115(11):1664-9.

PMID:
12609084
20.

Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39. doi: 10.1158/1078-0432.CCR-07-4126.

Supplemental Content

Support Center